Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleClinical Investigations

18F-FDG PET/CT: Therapy Response Assessment Interpretation (Hopkins Criteria) and Survival Outcomes in Lung Cancer Patients

Sara Sheikhbahaei, Esther Mena, Charles Marcus, Rick Wray, Mehdi Taghipour and Rathan M. Subramaniam
Journal of Nuclear Medicine June 2016, 57 (6) 855-860; DOI: https://doi.org/10.2967/jnumed.115.165480
Sara Sheikhbahaei
1Russell H. Morgan Department of Radiology and Radiological Sciences, Baltimore, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Esther Mena
1Russell H. Morgan Department of Radiology and Radiological Sciences, Baltimore, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles Marcus
1Russell H. Morgan Department of Radiology and Radiological Sciences, Baltimore, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rick Wray
1Russell H. Morgan Department of Radiology and Radiological Sciences, Baltimore, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mehdi Taghipour
1Russell H. Morgan Department of Radiology and Radiological Sciences, Baltimore, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rathan M. Subramaniam
1Russell H. Morgan Department of Radiology and Radiological Sciences, Baltimore, Maryland
2Department of Oncology of Johns Hopkins School of Medicine, Baltimore, Maryland; and
3Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 57 no. 6 855-860
DOI 
https://doi.org/10.2967/jnumed.115.165480
PubMed 
26837337

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication August 12, 2015
  • Accepted for publication January 7, 2016
  • Published online June 1, 2016.

Article Versions

  • previous version (February 2, 2016 - 07:05).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2016 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Author Information

  1. Sara Sheikhbahaei1,
  2. Esther Mena1,
  3. Charles Marcus1,
  4. Rick Wray1,
  5. Mehdi Taghipour1 and
  6. Rathan M. Subramaniam1–3
  1. 1Russell H. Morgan Department of Radiology and Radiological Sciences, Baltimore, Maryland
  2. 2Department of Oncology of Johns Hopkins School of Medicine, Baltimore, Maryland; and
  3. 3Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
  1. For correspondence or reprints contact: Rathan M. Subramaniam, Russell H. Morgan Department of Radiology and Radiology Science, Johns Hopkins Medical Institutions, 601 N. Caroline St., JHOC 3235, Baltimore, MD 21287. E-mail: rsubram4{at}jhmi.edu
View Full Text

Statistics from Altmetric.com

Cited By...

  • 42 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • The Value of FDG PET/CT in Treatment Response Assessment, Follow-Up, and Surveillance of Lung Cancer
    Sara Sheikhbahaei, Esther Mena, Anusha Yanamadala, Siddaling Reddy, Lilja B. Solnes, Jason Wachsmann, Rathan M. Subramaniam
    American Journal of Roentgenology 2017 208 2
  • Artificial intelligence-based prediction of clinical outcome in immunotherapy and targeted therapy of lung cancer
    Xiaomeng Yin, Hu Liao, Hong Yun, Nan Lin, Shen Li, Yu Xiang, Xuelei Ma
    Seminars in Cancer Biology 2022 86
  • A physics-guided modular deep-learning based automated framework for tumor segmentation in PET
    Kevin H Leung, Wael Marashdeh, Rick Wray, Saeed Ashrafinia, Martin G Pomper, Arman Rahmim, Abhinav K Jha
    Physics in Medicine & Biology 2020 65 24
  • MicroRNA-125a-5p plays a role as a tumor suppressor in lung carcinoma cells by directly targeting STAT3
    Lou Zhong, Siyuan Sun, Jiahai Shi, Fei Cao, Xiao Han, Zhong Chen
    Tumor Biology 2017 39 6
  • Joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[18F]FDG PET/CT external beam radiation treatment planning in lung cancer V1.0
    Sofia C. Vaz, Judit A. Adam, Roberto C. Delgado Bolton, Pierre Vera, Wouter van Elmpt, Ken Herrmann, Rodney J. Hicks, Yolande Lievens, Andrea Santos, Heiko Schöder, Bernard Dubray, Dimitris Visvikis, Esther G. C. Troost, Lioe-Fee de Geus-Oei
    European Journal of Nuclear Medicine and Molecular Imaging 2022 49 4
  • Local control and vertebral compression fractures following stereotactic body radiotherapy for spine metastases
    Yurday Ozdemir, Nese Torun, Ozan Cem Guler, Berna Akkus Yildirim, Ali A. Besen, Aylin Gunesli Yetisken, H. Cem Onal, Erkan Topkan
    Journal of Bone Oncology 2019 15
  • What 18F-FDG PET Response-Assessment Method Best Predicts Survival After Curative-Intent Chemoradiation in Non–Small Cell Lung Cancer: EORTC, PERCIST, Peter Mac Criteria, or Deauville Criteria?
    Guy-Anne Turgeon, Amir Iravani, Tim Akhurst, Alexis Beaulieu, Jason W. Callahan, Mathias Bressel, Aidan J. Cole, Sarah J. Everitt, Shankar Siva, Rodney J. Hicks, David L. Ball, Michael P. Mac Manus
    Journal of Nuclear Medicine 2019 60 3
  • Efficacy of qualitative response assessment interpretation criteria at 18F-FDG PET-CT for predicting outcome in locally advanced cervical carcinoma treated with chemoradiotherapy
    Andrew Scarsbrook, Sriram Vaidyanathan, Fahmid Chowdhury, Sarah Swift, Rachel Cooper, Chirag Patel
    European Journal of Nuclear Medicine and Molecular Imaging 2017 44 4
  • Lung Cancer Recurrence: 18F-FDG PET/CT in Clinical Practice
    Asha Kandathil, Robert Carson Sibley III, Rathan M. Subramaniam
    American Journal of Roentgenology 2019 213 5
  • 18F-FDG PET/CT in Restaging and Evaluation of Response to Therapy in Lung Cancer: State of the Art
    Angelo Castello, Sabrina Rossi, Egesta Lopci
    Current Radiopharmaceuticals 2020 13 3

Article usage

Article usage: March 2016 to May 2025

AbstractFullPdf
Feb 2016503081
Mar 2016166027
Apr 201696027
May 2016134015
Jun 2016118828117
Jul 20163041243
Aug 2016146718
Sep 2016112418
Oct 2016112819
Nov 201689619
Dec 2016741723
Jan 2017751627
Feb 2017542323
Mar 2017722831
Apr 2017542034
May 2017331628
Jun 2017613453
Jul 2017271732
Aug 2017281529
Sep 2017252632
Oct 2017454326
Nov 2017394423
Dec 2017292422
Jan 2018273623
Feb 2018243621
Mar 2018172510
Apr 2018213024
May 2018172819
Jun 2018171114
Jul 20188229
Aug 2018132813
Sep 2018174431
Oct 2018163720
Nov 2018251721
Dec 2018122312
Jan 2019222618
Feb 2019202116
Mar 2019174526
Apr 2019121920
May 2019193421
Jun 201962020
Jul 2019202017
Aug 2019211912
Sep 2019151514
Oct 2019112515
Nov 2019193433
Dec 2019111069
Jan 2020174819
Feb 2020152518
Mar 2020102821
Apr 2020241413
May 202082219
Jun 202083112
Jul 202012126
Aug 2020192315
Sep 2020122520
Oct 2020101913
Nov 2020111923
Dec 20206137
Jan 202143422
Feb 2021106833
Mar 2021115530
Apr 202144829
May 202184224
Jun 202155321
Jul 202113931
Aug 202113417
Sep 202123115
Oct 202146933
Nov 202103834
Dec 202155634
Jan 2022195037
Feb 202257324
Mar 202237228
Apr 202284926
May 202237939
Jun 202227026
Jul 202266617
Aug 202295218
Sep 202245013
Oct 202244617
Nov 202225524
Dec 202237319
Jan 202376427
Feb 202344011
Mar 202365117
Apr 202365923
May 202355117
Jun 202324916
Jul 202345524
Aug 202304322
Sep 202325419
Oct 202304814
Nov 202396121
Dec 202376712
Jan 202425512
Feb 2024235725
Mar 202454558
Apr 2024811024
May 202445122
Jun 202484218
Jul 2024138930
Aug 202476715
Sep 202437021
Oct 2024710732
Nov 202449719
Dec 202428611
Jan 2025110225
Feb 2025412524
Mar 2025611930
Apr 2025614928
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 57 (6)
Journal of Nuclear Medicine
Vol. 57, Issue 6
June 1, 2016
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
18F-FDG PET/CT: Therapy Response Assessment Interpretation (Hopkins Criteria) and Survival Outcomes in Lung Cancer Patients
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
18F-FDG PET/CT: Therapy Response Assessment Interpretation (Hopkins Criteria) and Survival Outcomes in Lung Cancer Patients
Sara Sheikhbahaei, Esther Mena, Charles Marcus, Rick Wray, Mehdi Taghipour, Rathan M. Subramaniam
Journal of Nuclear Medicine Jun 2016, 57 (6) 855-860; DOI: 10.2967/jnumed.115.165480

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
18F-FDG PET/CT: Therapy Response Assessment Interpretation (Hopkins Criteria) and Survival Outcomes in Lung Cancer Patients
Sara Sheikhbahaei, Esther Mena, Charles Marcus, Rick Wray, Mehdi Taghipour, Rathan M. Subramaniam
Journal of Nuclear Medicine Jun 2016, 57 (6) 855-860; DOI: 10.2967/jnumed.115.165480
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • RESISTing the Need to Quantify: Putting Qualitative FDG-PET/CT Tumor Response Assessment Criteria into Daily Practice
  • What 18F-FDG PET Response-Assessment Method Best Predicts Survival After Curative-Intent Chemoradiation in Non-Small Cell Lung Cancer: EORTC, PERCIST, Peter Mac Criteria, or Deauville Criteria?
  • Clinical Indications and Impact on Management: Fourth and Subsequent Posttherapy Follow-up 18F-FDG PET/CT Scans in Oncology Patients
  • Google Scholar

More in this TOC Section

  • Feasibility of Ultra-Low-Activity 18F-FDG PET/CT Imaging Using a Long–Axial-Field-of-View PET/CT System
  • Cardiac Presynaptic Sympathetic Nervous Function Evaluated by Cardiac PET in Patients with Chronotropic Incompetence Without Heart Failure
  • Validation and Evaluation of a Vendor-Provided Head Motion Correction Algorithm on the uMI Panorama PET/CT System
Show more Clinical Investigations

Similar Articles

Keywords

  • PET/CT
  • lung cancer
  • Therapy assessment
  • survival
SNMMI

© 2025 SNMMI

Powered by HighWire